Inspire Medical Systems (INSP) Tops Q1 EPS by 34c, provides guidance

Inspire Medical Systems (NYSE: INSP) reported Q1 EPS of $0.10, $0.34 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $201.3 million versus the consensus estimate of $195.2 million.

GUIDANCE:

Inspire Medical Systems sees FY2025 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.16. Inspire Medical Systems sees FY2025 revenue of $940-955 million, versus the consensus of $949.2 million.

For earnings history and earnings-related data on Inspire Medical Systems (INSP) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Paycom Software (PAYC) PT Raised to $285 at UBS
• BTIG Upgrades Tidewater Inc (TDW) to Buy, 'Increasing Activity Set To Push Dayrates Higher in Key Basins'